Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04149145
Title Trial of M4344 and Niraparib in Patients With Poly (ADP-ribose) Polymerase (PARP) Resistant Recurrent Ovarian Cancer
Recruitment Not yet recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors University of Alabama at Birmingham

peritoneum cancer

fallopian tube cancer

ovary serous adenocarcinoma


Niraparib + VX-803

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.